Related references
Note: Only part of the references are listed.Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity
Stanley L. Hazen
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice
Stephen J. Peterson et al.
JOURNAL OF LIPID RESEARCH (2008)
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I
Brian J. Van Lenten et al.
JOURNAL OF LIPID RESEARCH (2008)
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LeAnne T. Bloedon et al.
JOURNAL OF LIPID RESEARCH (2008)
The lipid whisker model of the structure of oxidized cell membranes
Michael E. Greenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Long-term treatment with the apoliprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats
Stephen J. Peterson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36
Xin-Min Li et al.
BIOCHEMISTRY (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers
Shaila P. Handattu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
G. M. Anantharamaiah et al.
JOURNAL OF LIPID RESEARCH (2007)
Association of a model class a (apolipoprotein) amphipathic α helical peptide with lipid -: High resolution NMR studies of peptide-lipid discoidal complexes
VK Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide
H Gupta et al.
CIRCULATION RESEARCH (2005)
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes
AL Kruger et al.
CIRCULATION (2005)
Two homologous apolipoprotein AI mimetic peptides - Relationship between membrane interactions and biological activity
RM Epand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes
BJ Van Lenten et al.
CIRCULATION (2004)
Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
M Navab et al.
CIRCULATION (2004)
Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity
G Datta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cationic DMPC/DMTAP lipid bilayers: Molecular dynamics study
AA Gurtovenko et al.
BIOPHYSICAL JOURNAL (2004)
An apolipoprotein AI mimetic peptide: Membrane interactions and the role of cholesterol
RM Epand et al.
BIOCHEMISTRY (2004)
L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease
JS Ou et al.
CIRCULATION (2003)
L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells
ZJ Ou et al.
CIRCULATION (2003)
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide
BJ Van Lenten et al.
CIRCULATION (2002)
Solution NMR structure of a model class A (apolipoprotein) amphipathic α helical peptide
VK Mishra et al.
PEPTIDES (2001)
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
EA Podrez et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
